Key result
ICU admission exposes ~72% of patients to potential drug-drug interactions.
Why the study?
Intensive care unit patients are especially prone to potential drug-drug interactions, and this study aimed to determine their frequency and severity during ICU hospitalization.
Population
232 ICU patients across three hospitals in Nablus, Palestine
Design
Retrospective multicenter study
Authors
Loading...
High pDDI prevalence in ICU warrants closer monitoring; retrospective data leaves open prospective validation and intervention trials.
Observational (n=232)
Yes
Potential drug-drug interactions are highly prevalent (72%) in ICU patients, with polypharmacy significantly increasing the risk, highlighting the need for careful medication review.
Ali et al. (2020) conducted an observational in ICU patients (n=232). Polypharmacy / Potential drug-drug interactions was evaluated on Frequency and severity of potential drug-drug interactions (pDDIs). Among 232 ICU patients, 72% experienced at least one potential drug-drug interaction, with a total of 422 interactions identified, of which 9.7% were major.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: